CPA
VCYT icon

Capital Performance Advisors’s Veracyte VCYT Stock Holding History

Capital Performance Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-259
Closed -$8.82K – 2587
2024
Q3 		$8.82K Buy
+259
New +$7.29K ﹤0.01% 880

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Capital Performance Advisors's VCYT Position: Q4 2024 in Review

Capital Performance Advisors sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 259 shares — an estimated $8.82K sold.

Capital Performance Advisors first reported a position in VCYT in Q3 2024 and held it in 1 quarter. The position peaked at $8.82K in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Capital Performance Advisors reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 259 Veracyte shares in Q4 2024, an estimated $8.82K.
  • Capital Performance Advisors first reported a position in Veracyte in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Veracyte position peaked at $8.82K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.